InsidersTradesSigma
Track the 카나프테라퓨틱스 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 카나프테라퓨틱스 has recorded 3 insider filings. Market capitalisation: €252.9bn. The latest transaction was disclosed on 23 March 2026 (Purchase). Among the most active insiders: 김동건. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations